INTERNATIONAL STRATEGIC HEALTHCARE COMMUNICATIONS

Experienced, trusted advisors to some of the world's most exciting public and private companies across pharmaceuticals, medtech, digital health, biotech and healthcare services, large & small.

WHAT WE DO

COMMUNICATING A COMPELLING GROWTH STORY TO THE INVESTMENT COMMUNITY

Effectively communicating a company’s strategy, growth ambitions, and the reasons to “invest now” is critical for management teams as they seek to build investor confidence and support. We have an exceptional track record in advising globally on healthcare fund raisings, IPOs and M&A transactions.

FIND OUT MORE

Insights & Latest News

Verona Pharma ($VRNA) will report top-line #Phase3 data from its ENHANCE-2 trial in #COPD and its results for the second quarter ended June 30, 2022 on August 9. The Company will host a call with a KOL to discuss the trial results. See more here: http://bit.ly/3BQIQP5

Verona Pharma ($VRNA) is pleased to announce positive top-line #Phase3 data from its ENHANCE-2 trial in #COPD. The trial met the primary and secondary endpoints demonstrating improvements in lung function. See more detail here: http://bit.ly/3JI4WF3

Optimum's 14th Annual

Healthcare Investor Conference

6th October 2022 | The Wellcome Collection, London

More info

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH